A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer

This study has been withdrawn prior to enrollment.
(Protocol not activated.)
Sponsor:
Information provided by (Responsible Party):
Oncoceutics, Inc.
ClinicalTrials.gov Identifier:
NCT02038699
First received: January 14, 2014
Last updated: December 18, 2015
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)